Novel triple GLP-1 / GIP / glucagon receptor agonist and a pharmaceutical composition for preventing or treating obesity comprising the same
MYPI2025003834A0Undetermined Publication Date: 2024-06-23HANMI PHARM CO LTD
View PDF 0 Cites 0 Cited by
Patent Information
- Application Number
- MYPI2025003834
- Authority / Receiving Office
- MY · MY
- Patent Type
- Applications
- Current Assignee / Owner
- Priority Date
- 2022-12-23
- Filing Date
- 2023-12-22
- Publication Date
- 2024-06-23
Abstract
The present disclosure relates to a novel triple agonist having activities for all of GLP-1, GIP, and glucagon receptors, and use of the triple agonist for the prevention or treatment of obesity.
Need to check novelty before this filing date? Find Prior Art
